SC refuses to entertain PIL raising concerns over HPV vaccination campaign
The top court orally said that the PIL was filed with an ulterior motive and lacked bonafide
The Supreme Court of India rejected a petition on Thursday that raised concerns about the nationwide human papillomavirus (HPV) vaccination campaign for adolescent girls, aiming to prevent cervical cancer. Chief Justice of India Surya Kant, along with Justices Joymalya Bagchi and V. Mohana, stated that in cases of improper vaccination, standard compensation rules would be applied.
The Delhi High Court also decided not to halt the HPV vaccination drive and requested a response from the central government. The court was deliberating a public interest litigation filed by the Universal Health Organisation, which questioned the implementation of the government-supported HPV vaccination program, citing potential violations of constitutional rights such as informed consent, bodily autonomy, transparency, and accountability.
The plea highlighted issues like free vaccines, a single-dose strategy, and concerns about the vaccine's safety and long-term effects. An ongoing study by the Indian Council of Medical Research (ICMR) is assessing whether a single dose of the domestically produced Cervavac vaccine provides sufficient protection compared to the two-dose Gardasil vaccine.
Written by urgent.news from The Hindu Health's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
This story
This is one outlet's version. Read the fullest account.
